GenXys Health Care Systems provides safe, effective and personalized prescribing options to consumers and health care professionals.
“Personalized medicine”, healthcare based on integrating information from the unique molecular makeup of each individual, is changing the face of healthcare. Personalized medicine has the potential to address the problems identified and reduce costs of healthcare and improve both patient and provider experience.
GenXys was formed in 2014 by a professional team of academic, biomedical, and technical experts with the vision to create improved health outcomes by enabling the personalisation of medication prescription decisions utilizing our two key products – myPGx and TreatGx.
Director of New Ventures, Sean Lumb and Life Sciences EIR, Karen Boodram, have been actively working with the founders of the company.